Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Haemonetics 4th Quarter and Fiscal 2019 Earnings Release Available on Investor Relations Website

HAE

Financial release accessible online

BRAINTREE, Mass., May 7, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its fourth quarter and fiscal year ended March 30, 2019 are available on its Investor relations website.

HAE logo April 2016.

The Company is posting the earnings release and results tables that will be referenced on its webcast to its Investor Relations website. 

Direct link to Earnings Release 4Q and FY19:

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDE4OTc3fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636924163445225608

Direct link to Results Tables 4Q and FY19 That Will Be Referenced on Webcast:

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDE4OTc2fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636924163445225608

As previously announced, the Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8:00am Eastern Time on May 7, 2019. The call can be accessed with the following information:

  • U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
  • Conference ID required for access: 4378487
  • A live webcast of the call can be accessed on Haemonetics' investor relations website.
  • Direct link to Conference Call Webcast: https://edge.media-server.com/m6/p/299h3spu

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.  

Investor Contacts         

Media Contact

Gerry Gould, VP-Investor Relations       

Carla Burigatto, VP-Communications

(781) 356-9402   

(781) 348-7263

gerry.gould@haemonetics.com 

carla.burigatto@haemonetics.com 



Olga Vlasova, Sr. Mgr.-Investor Relations


(781) 356 9763


olga.vlasova@haemonetics.com


         

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-4th-quarter-and-fiscal-2019-earnings-release-available-on-investor-relations-website-300844455.html

SOURCE Haemonetics Corporation



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today